Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Corengi
AddedFeb 19, 2024
UpdatedJun 18, 2026
Corengi

Corengi

Corengi: A technology platform connecting patients with suitable clinical trials, initially for type 2 diabetes.

HQ
Seattle, WA, US
Founded
2010
Overview
Compare
Fundraising
Employees

Corengi's mission is to connect patients with suitable clinical trials through a free and interactive platform. Their technology, accessible via a dedicated website and an embeddable widget, serves as a comprehensive matching engine. Initially focused on type 2 diabetes, Corengi is expanding its services with funding from an NIH SBIR grant.

Corengi has made significant strides in improving patient access to clinical trials, leveraging advanced technology to streamline the matching process. Their platform has garnered attention for its user-friendly interface and effectiveness in connecting patients with relevant trials, contributing to advancements in medical research and patient care.

Corengi - Similar Companies

Clinical Platform logo

Clinical Platform

FindMeCure logo

FindMeCure

findmecure.com

Power Life Science logo

Power Life Science

withpower.com

Leapcure logo

Leapcure

leapcure.com

Carebox logo

Carebox

careboxhealth.com

ClinOne logo

ClinOne

clinone.com

knowRX logo

knowRX

knowrxhealth.com

Curebase logo

Curebase

curebase.com

Leal Health logo

Leal Health

leal.health

Citruslabs logo

Citruslabs

citruslabs.com

Biogenesis Trials logo

Biogenesis Trials

mybiogenesis.com

Endpoint Clinical logo

Endpoint Clinical

Clinical Research IO logo

Clinical Research IO

HealClick logo

HealClick

healclick.com

On-Time Trials logo

On-Time Trials

ontimetrials.com

Corengi - Quick Facts

Who are Corengi's competitors?

Companies similar to Corengi include Clinical Platform, FindMeCure, Power Life Science and Leapcure.

When was Corengi founded?

Corengi was founded in 2010.

Where is Corengi's headquarters located?

Corengi's headquarters is located in Seattle, WA, US.

When was Corengi's last funding round?

Corengi's most recent funding round was for $277.5k (USD) in December 2012.

How much has Corengi raised to-date?

As of Dec 1, 2012, Corengi has raised a total of $322.5k (USD).

How many employees does Corengi have?

Corengi has 30 employees as of Feb 5, 2024.

Corengi - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Consumers
Main Product
  • Clinical Trials
Tags
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified